Clinical Trial

Prevalence of Sarcopenia-Promoting Medicines in Patients With Sarcopenia and Falls

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
Sarcopenia, characterised by the loss of muscle mass and function, is a common condition among the elderly and is often associated with increased risk of falls. Certain medications, such as glucocorticoids, statins, and some antipsychotics, may exacerbate sarcopenia, leading to a higher incidence of falls. This study aims to explore the prevalence of such medicines in patients diagnosed with sarcopenia who have experienced falls. Understanding the impact of these medications on sarcopenia and fall risk can inform clinical guidelines and improve patient outcomes.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-08-10; most recent amendment 2026-06-11.
Status change: Not Yet Recruiting → Enrolling by Invitation 2026-06-11
Trial Details
NCT Number NCT07127692
Lead Sponsor Medway NHS Foundation Trust
Conditions Sarcopenia in Elderly, Falls
Enrollment 100 participants
Start Date 2025-09-04
Primary Completion 2027-02 (estimated)
Study Completion 2027-04 (estimated)
Updated on ClinicalTrials.gov 2026-06-16